A
$ Value
$0
Shares
82,750
Price
$0
Filed
Jun 4
Insider
Name
Kelly John Alexander
Title
Chief Financial Officer
CIK
0001590030
Roles
Officer
Transaction Details
Transaction Date
2025-06-02
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
82,750
Footnotes
Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. | Award vests in three substantially equal annual installments beginning on February 17, 2026, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
Filing Info
Kelly John Alexander's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-18 | DTIL | ▼ | $31K |
| 2026-02-17 | DTIL | M | $0 |
| 2026-02-17 | DTIL | M | $0 |
| 2026-01-21 | DTIL | ▼ | $61K |
| 2026-01-20 | DTIL | M | — |
| 2026-01-20 | DTIL | M | — |
| 2026-01-20 | DTIL | M | — |
| 2026-01-20 | DTIL | M | $0 |
| 2026-01-20 | DTIL | M | $0 |
| 2026-01-20 | DTIL | M | $0 |
Other Insiders at DTIL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Kelly John Alexander
Chief Financial Officer
|
— | $31K | 2026-02-18 |
|
SMITH J. JEFFERSON
Chief Research Officer
|
— | $19K | 2026-02-18 |
|
Scimeca Dario
General Counsel and Secretary
|
— | $19K | 2026-02-18 |
|
Amoroso Michael
President and CEO
|
— | $79K | 2026-02-18 |